Helen Bramlett
Member of Scientific Advisory BoardDr. Helen Bramlett, PH.D. serves as Member of Scientific Advisory Board of ZyVersa Therapeutics, Inc. (formerly Variant Pharmaceuticals, Inc.). Dr. Bramlett is actively involved in undergraduate teaching and serves as Director of the Undergraduate Neuroscience Program at the University of Miami. Dr. Bramlett is an internationally recognized scientist with over 20 years’ experience in the field of CNS injury including the pathophysiology and treatment of traumatic brain and spinal cord injury as well as stroke. Her laboratory focuses on three areas of traumatic research: 1) neuroprotective strategies for traumatic injury, 2) progressive damage after trauma and 3) secondary injury mechanisms of traumatic brain injury. She is currently funded by NIH, DOD, the State of Florida and the VA. Dr. Bramlett serves on several national review boards and is on the Editorial Board of Journal of Neurotrauma and Translational Stroke Research. She is the Managing Editor of Therapeutic Hypothermia and Temperature Management. She is a founding member of the InflamaCORE, LLC, a company dedicated to treating and diagnosing inflammatory injury and disease. Dr. Bramlett received her bachelor’s degree in Psychology at the University of Texas at Austin, her MS in Psychology at the University of Louisiana at Monroe and her MS and PhD degrees in Behavioral Neuroscience from the University of Miami. She completed her postdoctoral work in Neurotrauma at the University of Miami and she received a postdoctoral fellowship award from the American Heart Association.
Positions
- Company NameZyVersa Therapeutics, Inc.Stock CodeZVSAPositionMember of Scientific Advisory Board
